SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes

Conditions:   Type2diabetes;   PreDiabetes;   Renal Failure Interventions:   Drug: Dapagliflozin (Forxiga®);   Drug: Placebo matching Dapaglifolzin;   Behavioral: Lifestyle Intervention Sponsors:   University Hospital Tuebingen;   German Federal Ministry of Education and Research;   German Center for Diabetes Research;   AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials